BREATHER (PENTA 16) short-cycle therapy (SCT) (5 days on/2 days off) in young people with chronic human immunodeficiency virus infection: an open, randomised, parallel-group Phase II/III trial.

Butler, K; Inshaw, J; Ford, D; Bernays, S; Scott, K; Kenny, J; Klein, N; Turkova, A; Harper, L; Nastouli, E; +5 more... Paparini, S; Choudhury, R; Rhodes, T; Babiker, A; Gibb, D; (2016) BREATHER (PENTA 16) short-cycle therapy (SCT) (5 days on/2 days off) in young people with chronic human immunodeficiency virus infection: an open, randomised, parallel-group Phase II/III trial. Health technology assessment (Winchester, England), 20 (49). pp. 1-108. ISSN 1366-5278 DOI: https://doi.org/10.3310/hta20490

Permanent Identifier

Use this Digital Object Identifier when citing or linking to this resource.

https://doi.org/10.3310/hta20490

Abstract

Share

Download

Filename: FullReport-hta20490.pdf

Licence: Open Government License

Download
[img]

Downloads

View details

Metrics & Citations


Google Scholar